Bridgeway Capital Management, LLC Coherus Bio Sciences, Inc. Transaction History
Bridgeway Capital Management, LLC
- $3.75 Billion
- Q1 2025
A detailed history of Bridgeway Capital Management, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 143,000 shares of CHRS stock, worth $131,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143,000
Previous 203,000
29.56%
Holding current value
$131,560
Previous $280,000
58.93%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CHRS
# of Institutions
121Shares Held
63.5MCall Options Held
127KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$9.72 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.84 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.69 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.79 Million0.11% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $71.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...